Skip to main content
Erschienen in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie 2/2017

11.11.2016 | Review Article/Brief Review

The biology of addiction

Erschienen in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

In this narrative review, the neurobiological mechanisms underlying substance abuse and addiction are discussed with a particular emphasis on the mechanisms that promote ongoing use and relapse. Addiction is estimated to affect 10-15% or more of the adult population, including physicians. Genetic predisposition, psychological and environmental risk factors, the timing of exposure to the substance, the type of substance used, and the frequency of use influence the individual’s susceptibility to addiction. Abused substances act on the brain’s reward system, a neural circuit that produces pleasurable feelings in response to stimuli that promote survival, thereby modifying future behavior to seek out similar stimuli. Endogenous activators include food, sex, and social interaction. Drugs of abuse hijack the reward circuit, producing intense activation. Repetitive exposure to substances leads to persistent, altered genetic expression and accumulation of ΔFos-B and corticotropin-releasing factor. High levels of these substances suppress the reward circuit and activate the endogenous stress response, resulting in a generalized state of discord. These changes are enduring and can trigger substance use relapse even after long periods of abstinence.
Literatur
2.
Zurück zum Zitat Lewis PC. Tobacco: what is it and why do people continue to use it? Medsurg Nurs 2008; 17: 193-201.PubMed Lewis PC. Tobacco: what is it and why do people continue to use it? Medsurg Nurs 2008; 17: 193-201.PubMed
3.
Zurück zum Zitat Beauchamp GA, Winstanley EL, Ryan SA, Lyons MS. Moving beyond misuse and diversion: the urgent need to consider the role of iatrogenic addiction in the current opioid epidemic. Am J Public Health 2014; 104: 2023-9.CrossRefPubMedPubMedCentral Beauchamp GA, Winstanley EL, Ryan SA, Lyons MS. Moving beyond misuse and diversion: the urgent need to consider the role of iatrogenic addiction in the current opioid epidemic. Am J Public Health 2014; 104: 2023-9.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Boys A, Marsden J, Strang J. Understanding reasons for drug use amongst young people: a functional perspective. Health Educ Res 2001; 16: 457-69.CrossRefPubMed Boys A, Marsden J, Strang J. Understanding reasons for drug use amongst young people: a functional perspective. Health Educ Res 2001; 16: 457-69.CrossRefPubMed
5.
Zurück zum Zitat Bye A. Experiments with cocaine and heroin addicts - are they predictive? Curr Opin Pharmacol 2014; 14: 74-80.CrossRefPubMed Bye A. Experiments with cocaine and heroin addicts - are they predictive? Curr Opin Pharmacol 2014; 14: 74-80.CrossRefPubMed
7.
Zurück zum Zitat Foster K, Spencer D. ‘It’s just a social thing’: drug use, friendship and borderwork among marginalized young people. Int J Drug Policy 2013; 24: 223-30.CrossRefPubMed Foster K, Spencer D. ‘It’s just a social thing’: drug use, friendship and borderwork among marginalized young people. Int J Drug Policy 2013; 24: 223-30.CrossRefPubMed
9.
Zurück zum Zitat Volkow ND, Baler RD. Addiction science: uncovering neurobiological complexity. Neuropharmacology 2014; 76 Pt B: 235-49. Volkow ND, Baler RD. Addiction science: uncovering neurobiological complexity. Neuropharmacology 2014; 76 Pt B: 235-49.
10.
11.
Zurück zum Zitat Milton AL, Everitt BJ. The persistence of maladaptive memory: addiction, drug memories and anti-relapse treatments. Neurosci Biobehav Rev 2012; 36: 1119-39.CrossRefPubMed Milton AL, Everitt BJ. The persistence of maladaptive memory: addiction, drug memories and anti-relapse treatments. Neurosci Biobehav Rev 2012; 36: 1119-39.CrossRefPubMed
12.
Zurück zum Zitat Anonymous Alcoholics. Alcoholics Anonymous. 4th ed. NY: A.A. World Services, Inc.; 2001 . Anonymous Alcoholics. Alcoholics Anonymous. 4th ed. NY: A.A. World Services, Inc.; 2001 .
13.
Zurück zum Zitat Latt N, Konigrave K, Saunders JB, Marshall EJ, Nutt D. Addiction Medicine. USA: Oxford University Press; 2009 .CrossRef Latt N, Konigrave K, Saunders JB, Marshall EJ, Nutt D. Addiction Medicine. USA: Oxford University Press; 2009 .CrossRef
14.
Zurück zum Zitat Sporns O. Networks of the Brain. Cambridge, MA: The MIT Press; 2010 . Sporns O. Networks of the Brain. Cambridge, MA: The MIT Press; 2010 .
15.
Zurück zum Zitat Nestler EJ, Hyman SE, Holtzman DM, Malenka RC. Molecular Neuropharmacology: A Foundation for Clinical Neuroscience. 3rd ed. NY: McGraw-Hill Medical; 2015 . Nestler EJ, Hyman SE, Holtzman DM, Malenka RC. Molecular Neuropharmacology: A Foundation for Clinical Neuroscience. 3rd ed. NY: McGraw-Hill Medical; 2015 .
16.
Zurück zum Zitat Gardner EL. Brain-reward mechanisms. In: Lowinson JH, Ruitz P, Millman RB, Langrod JG, editors. Substance Abuse - A Comprehensive Textbook. 4th ed. PA: Lippincott Williams & Wilkins; 2005. p. 48-97. Gardner EL. Brain-reward mechanisms. In: Lowinson JH, Ruitz P, Millman RB, Langrod JG, editors. Substance Abuse - A Comprehensive Textbook. 4th ed. PA: Lippincott Williams & Wilkins; 2005. p. 48-97.
17.
18.
Zurück zum Zitat Wise RA, Rompre PP. Brain dopamine and reward. Annu Rev Psychol 1989; 40: 191-225. Wise RA, Rompre PP. Brain dopamine and reward. Annu Rev Psychol 1989; 40: 191-225.
19.
Zurück zum Zitat Richard JM, Castro DC, Difeliceantonio AG, Robinson MJ, Berridge KC. Mapping brain circuits of reward and motivation: in the footsteps of Ann Kelley. Neurosci Biobehav Rev 2013; 37: 1919-31.CrossRefPubMed Richard JM, Castro DC, Difeliceantonio AG, Robinson MJ, Berridge KC. Mapping brain circuits of reward and motivation: in the footsteps of Ann Kelley. Neurosci Biobehav Rev 2013; 37: 1919-31.CrossRefPubMed
21.
Zurück zum Zitat Miendlarzewska EA, Bavelier D, Schwartz S. Influence of reward motivation on human declarative memory. Neurosci Biobehav Rev 2016; 61: 156-76.CrossRefPubMed Miendlarzewska EA, Bavelier D, Schwartz S. Influence of reward motivation on human declarative memory. Neurosci Biobehav Rev 2016; 61: 156-76.CrossRefPubMed
22.
Zurück zum Zitat Bowirrat A, Oscar-Berman M. Relationship between dopaminergic neurotransmission, alcoholism, and reward deficiency syndrome. Am J Med Genet B Neuropsychiatr Genet 2005; 132B: 29-37.CrossRefPubMed Bowirrat A, Oscar-Berman M. Relationship between dopaminergic neurotransmission, alcoholism, and reward deficiency syndrome. Am J Med Genet B Neuropsychiatr Genet 2005; 132B: 29-37.CrossRefPubMed
23.
Zurück zum Zitat Spanagel R, Weiss F. The dopamine hypothesis of reward: past and current status. Trends Neurosci 1999; 22: 521-7.CrossRefPubMed Spanagel R, Weiss F. The dopamine hypothesis of reward: past and current status. Trends Neurosci 1999; 22: 521-7.CrossRefPubMed
24.
Zurück zum Zitat Müller CP, Homberg JR. The role of serotonin in drug use and addiction. Behav Brain Res 2015; 277: 146-92.CrossRefPubMed Müller CP, Homberg JR. The role of serotonin in drug use and addiction. Behav Brain Res 2015; 277: 146-92.CrossRefPubMed
25.
Zurück zum Zitat Tzschentke TM, Schmidt WJ. Glutamatergic mechanisms in addiction. Mol Psychiatry 2003; 8: 373-82.CrossRefPubMed Tzschentke TM, Schmidt WJ. Glutamatergic mechanisms in addiction. Mol Psychiatry 2003; 8: 373-82.CrossRefPubMed
26.
27.
Zurück zum Zitat Volkow ND, Wang GJ, Fowler JS, Tomasi D. Addiction circuitry in the human brain. Annu Rev Pharmacol Toxicol 2012; 52: 321-36.CrossRefPubMed Volkow ND, Wang GJ, Fowler JS, Tomasi D. Addiction circuitry in the human brain. Annu Rev Pharmacol Toxicol 2012; 52: 321-36.CrossRefPubMed
29.
Zurück zum Zitat Salgado S, Kaplitt MG. The nucleus accumbens: a comprehensive review. Stereotact Funct Neurosurg 2015; 93: 75-93.CrossRefPubMed Salgado S, Kaplitt MG. The nucleus accumbens: a comprehensive review. Stereotact Funct Neurosurg 2015; 93: 75-93.CrossRefPubMed
30.
Zurück zum Zitat Kosten T, Scanley B, Tucker K, et al. Cue-induced brain activity changes and relapse in cocaine-dependent patients. Neuropsychopharmacology 2006; 31: 644-50.CrossRefPubMed Kosten T, Scanley B, Tucker K, et al. Cue-induced brain activity changes and relapse in cocaine-dependent patients. Neuropsychopharmacology 2006; 31: 644-50.CrossRefPubMed
31.
Zurück zum Zitat Volkow ND, Fowler JS, Wang GJ, et al. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 1993; 14: 169-77.CrossRefPubMed Volkow ND, Fowler JS, Wang GJ, et al. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 1993; 14: 169-77.CrossRefPubMed
32.
Zurück zum Zitat Goldstein RZ, Volkow ND. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 2002; 159: 1642-52.CrossRefPubMedPubMedCentral Goldstein RZ, Volkow ND. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 2002; 159: 1642-52.CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Olds J, Milner P. Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. J Comp Physiol Psychol 1954; 47: 419-27.CrossRefPubMed Olds J, Milner P. Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. J Comp Physiol Psychol 1954; 47: 419-27.CrossRefPubMed
35.
36.
Zurück zum Zitat Di Chiara G, Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 1988; 85: 5274-8.CrossRefPubMedPubMedCentral Di Chiara G, Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 1988; 85: 5274-8.CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Hyman SE, Malenka RC. Addiction and the brain: the neurobiology of compulsion and its persistence. Nat Rev Neurosci 2001; 2: 695-703.CrossRefPubMed Hyman SE, Malenka RC. Addiction and the brain: the neurobiology of compulsion and its persistence. Nat Rev Neurosci 2001; 2: 695-703.CrossRefPubMed
39.
Zurück zum Zitat Koob G, Le Moal M. Addiction and the brain antireward system. Annu Rev Psychol 2008; 59: 29-53.CrossRefPubMed Koob G, Le Moal M. Addiction and the brain antireward system. Annu Rev Psychol 2008; 59: 29-53.CrossRefPubMed
40.
Zurück zum Zitat Davey CG, Yücel M, Allen NB. The emergence of depression in adolescence: development of the prefrontal cortex and the representation of reward. Neurosci Biobehav Rev 2008; 32: 1-19.CrossRefPubMed Davey CG, Yücel M, Allen NB. The emergence of depression in adolescence: development of the prefrontal cortex and the representation of reward. Neurosci Biobehav Rev 2008; 32: 1-19.CrossRefPubMed
41.
Zurück zum Zitat Damez-Werno D, LaPlant Q, Sun H, et al. Drug experience epigenetically primes Fosb gene inducibility in rat nucleus accumbens. J Neurosci 2012; 32: 10267-72.CrossRefPubMedPubMedCentral Damez-Werno D, LaPlant Q, Sun H, et al. Drug experience epigenetically primes Fosb gene inducibility in rat nucleus accumbens. J Neurosci 2012; 32: 10267-72.CrossRefPubMedPubMedCentral
43.
44.
Zurück zum Zitat Volkow ND. The reality of comorbidity: depression and drug abuse. Biol Psychiatry 2004; 56: 714-7.CrossRefPubMed Volkow ND. The reality of comorbidity: depression and drug abuse. Biol Psychiatry 2004; 56: 714-7.CrossRefPubMed
45.
Zurück zum Zitat Dell’Osso L, Carmassi C, Mucci F, Marazziti D. Depression, serotonin and tryptophan. Curr Pharm Des 2016; 22: 949-54.CrossRefPubMed Dell’Osso L, Carmassi C, Mucci F, Marazziti D. Depression, serotonin and tryptophan. Curr Pharm Des 2016; 22: 949-54.CrossRefPubMed
46.
Zurück zum Zitat Naranjo CA, Tremblay LK, Busto UE. The role of the brain reward system in depression. Prog Neuropsychopharmacol Biol Psychiatry 2001; 25: 781-823.CrossRefPubMed Naranjo CA, Tremblay LK, Busto UE. The role of the brain reward system in depression. Prog Neuropsychopharmacol Biol Psychiatry 2001; 25: 781-823.CrossRefPubMed
47.
Zurück zum Zitat Nestler EJ, Carlezon WA Jr. The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 2006; 59: 1151-9.CrossRefPubMed Nestler EJ, Carlezon WA Jr. The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 2006; 59: 1151-9.CrossRefPubMed
48.
Zurück zum Zitat Belujon P, Grace AA. Hippocampus, amygdala and stress: interacting systems that affect susceptibility to addiction. Ann N Y Acad Sci 2011; 1216: 114-21.CrossRefPubMedPubMedCentral Belujon P, Grace AA. Hippocampus, amygdala and stress: interacting systems that affect susceptibility to addiction. Ann N Y Acad Sci 2011; 1216: 114-21.CrossRefPubMedPubMedCentral
49.
Zurück zum Zitat Smagin GN, Heinrichs SC, Dunn AJ. The role of CRH in behavioral responses to stress. Peptides 2001; 22: 713-24.CrossRefPubMed Smagin GN, Heinrichs SC, Dunn AJ. The role of CRH in behavioral responses to stress. Peptides 2001; 22: 713-24.CrossRefPubMed
50.
Zurück zum Zitat Vale W, Spiess J, Rivier C, Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 1981; 213: 1394-7.CrossRefPubMed Vale W, Spiess J, Rivier C, Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 1981; 213: 1394-7.CrossRefPubMed
51.
Zurück zum Zitat Rainnie DG, Bergeron R, Sajdyk TJ, Patil M, Gehlert DR, Shekhar A. Corticotrophin releasing factor-induced synaptic plasticity in the amygdala translates stress into emotional disorders. J Neurosci 2004; 24: 3471-9.CrossRefPubMed Rainnie DG, Bergeron R, Sajdyk TJ, Patil M, Gehlert DR, Shekhar A. Corticotrophin releasing factor-induced synaptic plasticity in the amygdala translates stress into emotional disorders. J Neurosci 2004; 24: 3471-9.CrossRefPubMed
52.
Zurück zum Zitat Arborelius L, Owens MJ, Plotsky PM, Nemeroff CB. The role of corticotropin-releasing factor in depression and anxiety disorders. J Endocrinol 1999; 160: 1-12.CrossRefPubMed Arborelius L, Owens MJ, Plotsky PM, Nemeroff CB. The role of corticotropin-releasing factor in depression and anxiety disorders. J Endocrinol 1999; 160: 1-12.CrossRefPubMed
53.
Zurück zum Zitat Silberman Y, Winder DG. Ethanol and corticotropin releasing factor receptor modulation of central amygdala neurocircuitry: an update and future directions. Alcohol 2015; 49: 179-84.CrossRefPubMedPubMedCentral Silberman Y, Winder DG. Ethanol and corticotropin releasing factor receptor modulation of central amygdala neurocircuitry: an update and future directions. Alcohol 2015; 49: 179-84.CrossRefPubMedPubMedCentral
54.
Zurück zum Zitat Yohn NL, Bartolomei MS, Blendy JA. Multigenerational and transgenerational inheritance of drug exposure: the effects of alcohol, opiates, cocaine, marijuana, and nicotine. Progr Biophys Mol Biol 2015; 118: 21-33.CrossRef Yohn NL, Bartolomei MS, Blendy JA. Multigenerational and transgenerational inheritance of drug exposure: the effects of alcohol, opiates, cocaine, marijuana, and nicotine. Progr Biophys Mol Biol 2015; 118: 21-33.CrossRef
55.
Zurück zum Zitat Han C, McGue MK, Iacono WG. Lifetime tobacco, alcohol and other substance use in adolescent Minnesota twins: univariate and multivariate behavioral genetic analyses. Addiction 1999; 94: 981-93.CrossRefPubMed Han C, McGue MK, Iacono WG. Lifetime tobacco, alcohol and other substance use in adolescent Minnesota twins: univariate and multivariate behavioral genetic analyses. Addiction 1999; 94: 981-93.CrossRefPubMed
56.
Zurück zum Zitat Agrawal A, Lynskey MT. Are there genetic influences on addiction: evidence from family, adoption and twin studies. Addiction 2008; 103: 1069-81.CrossRefPubMed Agrawal A, Lynskey MT. Are there genetic influences on addiction: evidence from family, adoption and twin studies. Addiction 2008; 103: 1069-81.CrossRefPubMed
57.
Zurück zum Zitat Bierut LJ, Dinwiddie SH, Begleiter H, et al. Familial transmission of substance dependence: alcohol, marijuana, cocaine, and habitual smoking: a report from the Collaborative Study on the Genetics of Alcoholism. Arch Gen Psychiatry 1998; 55: 982-8.CrossRefPubMed Bierut LJ, Dinwiddie SH, Begleiter H, et al. Familial transmission of substance dependence: alcohol, marijuana, cocaine, and habitual smoking: a report from the Collaborative Study on the Genetics of Alcoholism. Arch Gen Psychiatry 1998; 55: 982-8.CrossRefPubMed
58.
Zurück zum Zitat Li MD, Cheng R, Ma JZ, Swan GE. A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins. Addiction 2003; 98: 23-31.CrossRefPubMed Li MD, Cheng R, Ma JZ, Swan GE. A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins. Addiction 2003; 98: 23-31.CrossRefPubMed
60.
Zurück zum Zitat Charbogne P, Kieffer B, Befort K. 15 years of genetic approaches in vivo for addiction research: opioid receptor and peptide gene knockout in mouse models of drug abuse. Neuropharmacology 2014; 76 Part B: 204-17. Charbogne P, Kieffer B, Befort K. 15 years of genetic approaches in vivo for addiction research: opioid receptor and peptide gene knockout in mouse models of drug abuse. Neuropharmacology 2014; 76 Part B: 204-17.
61.
Zurück zum Zitat Agrawal A, Pergadia ML, Saccone SF, et al. An autosomal linkage scan for cannabis use disorders in the nicotine addiction genetics project. Arch Gen Psychiatry 2008; 65: 713-21.CrossRefPubMed Agrawal A, Pergadia ML, Saccone SF, et al. An autosomal linkage scan for cannabis use disorders in the nicotine addiction genetics project. Arch Gen Psychiatry 2008; 65: 713-21.CrossRefPubMed
63.
64.
Zurück zum Zitat Conner BT, Hellemann GS, Ritchie TL, Noble EP. Genetic, personality, and environmental predictors of drug use in adolescents. J Substance Abuse Treat 2010; 38: 178-90.CrossRef Conner BT, Hellemann GS, Ritchie TL, Noble EP. Genetic, personality, and environmental predictors of drug use in adolescents. J Substance Abuse Treat 2010; 38: 178-90.CrossRef
65.
Zurück zum Zitat Grandy DK, Miller GM, Li JX. “TAARgeting Addiction”—The alamo bears witness to another revolution. Drug Alcohol Depend 2016; 159: 9-16.CrossRefPubMed Grandy DK, Miller GM, Li JX. “TAARgeting Addiction”—The alamo bears witness to another revolution. Drug Alcohol Depend 2016; 159: 9-16.CrossRefPubMed
66.
Zurück zum Zitat Saccone SF, Hinrichs AL, Saccone NL, et al. Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum Mol Genet 2007; 16: 36-49.CrossRefPubMed Saccone SF, Hinrichs AL, Saccone NL, et al. Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum Mol Genet 2007; 16: 36-49.CrossRefPubMed
67.
Zurück zum Zitat Mathews R, Hall W, Carter A. Direct-to-consumer genetic testing for addiction susceptibility: a premature commercialisation of doubtful validity and value. Addiction 2012; 107: 2069-74.CrossRefPubMed Mathews R, Hall W, Carter A. Direct-to-consumer genetic testing for addiction susceptibility: a premature commercialisation of doubtful validity and value. Addiction 2012; 107: 2069-74.CrossRefPubMed
68.
69.
Zurück zum Zitat Hall WD, Gartner CE, Carter A. The genetics of nicotine addiction liability: ethical and social policy implications. Addiction 2008; 103: 350-9.CrossRefPubMed Hall WD, Gartner CE, Carter A. The genetics of nicotine addiction liability: ethical and social policy implications. Addiction 2008; 103: 350-9.CrossRefPubMed
70.
Zurück zum Zitat Kim JK, Samaranayake M, Pradhan S. Epigenetic mechanisms in mammals. Cell Mol Life Sci 2009; 66: 596-612.CrossRefPubMed Kim JK, Samaranayake M, Pradhan S. Epigenetic mechanisms in mammals. Cell Mol Life Sci 2009; 66: 596-612.CrossRefPubMed
71.
Zurück zum Zitat Youngson NA, Whitelaw E. Transgenerational epigenetic effects. Annu Rev Genomics Hum Genet 2008; 9: 233-57.CrossRefPubMed Youngson NA, Whitelaw E. Transgenerational epigenetic effects. Annu Rev Genomics Hum Genet 2008; 9: 233-57.CrossRefPubMed
72.
Zurück zum Zitat Vassoler FM, Sadri-Vakili G. Mechanisms of transgenerational inheritance of addictive-like behaviors. Neuroscience 2014; 264: 198-206.CrossRefPubMed Vassoler FM, Sadri-Vakili G. Mechanisms of transgenerational inheritance of addictive-like behaviors. Neuroscience 2014; 264: 198-206.CrossRefPubMed
73.
Zurück zum Zitat Caldji C, Hellstrom IC, Zhang TY, Diorio J, Meaney MJ. Environmental regulation of the neural epigenome. FEBS Lett 2011; 585: 2049-58.CrossRefPubMed Caldji C, Hellstrom IC, Zhang TY, Diorio J, Meaney MJ. Environmental regulation of the neural epigenome. FEBS Lett 2011; 585: 2049-58.CrossRefPubMed
77.
Zurück zum Zitat Cheng MF. Hypothalamic neurogenesis in the adult brain. Front Neuroendocrinol 2013; 34: 167-78.CrossRefPubMed Cheng MF. Hypothalamic neurogenesis in the adult brain. Front Neuroendocrinol 2013; 34: 167-78.CrossRefPubMed
78.
Zurück zum Zitat Aguado T, Monory K, Palazuelos J, et al. The endocannabinoid system drives neural progenitor proliferation. FASEB J 2005; 19: 1704-6.PubMed Aguado T, Monory K, Palazuelos J, et al. The endocannabinoid system drives neural progenitor proliferation. FASEB J 2005; 19: 1704-6.PubMed
79.
Zurück zum Zitat Fontaine CJ, Patten AR, Sickmann HM, Helfer JL, Christie BR. Effects of pre-natal alcohol exposure on hippocampal synaptic plasticity: sex, age and methodological considerations. Neurosci Biobehav Rev 2016; 64: 12-34.CrossRefPubMed Fontaine CJ, Patten AR, Sickmann HM, Helfer JL, Christie BR. Effects of pre-natal alcohol exposure on hippocampal synaptic plasticity: sex, age and methodological considerations. Neurosci Biobehav Rev 2016; 64: 12-34.CrossRefPubMed
81.
Zurück zum Zitat Fuhrmann D, Knoll LJ, Blakemore SJ. Adolescence as a sensitive period of brain development. Trends Cogn Sci 2015; 19: 558-66.CrossRefPubMed Fuhrmann D, Knoll LJ, Blakemore SJ. Adolescence as a sensitive period of brain development. Trends Cogn Sci 2015; 19: 558-66.CrossRefPubMed
83.
Zurück zum Zitat Lubman DI, Cheetham A, Yücel M. Cannabis and adolescent brain development. Pharmacol Ther 2015; 148: 1-16.CrossRefPubMed Lubman DI, Cheetham A, Yücel M. Cannabis and adolescent brain development. Pharmacol Ther 2015; 148: 1-16.CrossRefPubMed
85.
Zurück zum Zitat Di Chiara G. Drug addiction as dopamine-dependent associative learning disorder. Eur J Pharmacol 1999; 375: 13-30.CrossRefPubMed Di Chiara G. Drug addiction as dopamine-dependent associative learning disorder. Eur J Pharmacol 1999; 375: 13-30.CrossRefPubMed
86.
Zurück zum Zitat Diekhof E, Falkai P, Gruber O. Functional neuroimaging of reward processing and decision-making: a review of aberrant motivational and affective processing in addiction and mood disorders. Brain Res Rev 2008; 59: 164-84.CrossRefPubMed Diekhof E, Falkai P, Gruber O. Functional neuroimaging of reward processing and decision-making: a review of aberrant motivational and affective processing in addiction and mood disorders. Brain Res Rev 2008; 59: 164-84.CrossRefPubMed
Metadaten
Titel
The biology of addiction
Publikationsdatum
11.11.2016
Erschienen in
Canadian Journal of Anesthesia/Journal canadien d'anesthésie / Ausgabe 2/2017
Print ISSN: 0832-610X
Elektronische ISSN: 1496-8975
DOI
https://doi.org/10.1007/s12630-016-0771-2

Weitere Artikel der Ausgabe 2/2017

Canadian Journal of Anesthesia/Journal canadien d'anesthésie 2/2017 Zur Ausgabe

Review Article/Brief Review

Professionalism in anesthesia

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.